Personalized combo therapy aims to outsmart Drug-Resistant lung cancer
Disease control
Not yet recruiting
This early-phase study tests whether adding the statin drug pitavastatin to standard chemotherapy can shrink tumors in people with advanced non-small cell lung cancer that no longer responds to second-line treatment. A lab test using the patient's own tumor cells will guide which…
Phase: PHASE1 • Sponsor: Chang Chen • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC